Marpai Inc (MRAI)

$0.6

+0.05

(+9.97%)▲

Market is closed - opens 7 PM, 11 Sep 2024

Performance

  • $0.52
    $0.69
    $0.60
    downward going graph

    13.33%

    Downside

    Day's Volatility :24.64%

    Upside

    13.04%

    downward going graph
  • $0.33
    $3.46
    $0.60
    downward going graph

    45.0%

    Downside

    52 Weeks Volatility :90.46%

    Upside

    82.66%

    downward going graph

Returns

PeriodMarpai IncIndex (Russel 2000)
3 Months
-18.82%
0.0%
6 Months
-64.8%
0.0%
1 Year
-8.0%
0.0%
3 Years
-96.37%
-20.6%

Highlights

Market Capitalization
7.6M
Book Value
- $2.33
Earnings Per Share (EPS)
-2.92
Wall Street Target Price
6.0
Profit Margin
-92.77%
Operating Margin TTM
-65.17%
Return On Assets TTM
-37.3%
Return On Equity TTM
-1359.59%
Revenue TTM
32.0M
Revenue Per Share TTM
3.59
Quarterly Revenue Growth YOY
-28.4%
Gross Profit TTM
7.2M
EBITDA
-18.4M
Diluted Eps TTM
-2.92
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
0.0
EPS Estimate Next Year
0.0
EPS Estimate Current Quarter
0.0
EPS Estimate Next Quarter
0.0

Analyst Recommendation

Buy
    85%Buy
    14%Hold
    0
    0%Sell
Based on 7 Wall street analysts offering stock ratings for Marpai Inc(by analysts ranked 0 to 5 stars)
Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 900.0%

Current $0.60
Target $6.00

Company Financials

FY20Y/Y Change
Revenue
3.5M
-
Net Income
-4.4M
↑ 163.91%
Net Profit Margin
-125.02%
-
FY21Y/Y Change
Revenue
14.2M
↑ 302.86%
Net Income
-16.0M
↑ 262.06%
Net Profit Margin
-112.36%
↑ 12.66%
FY22Y/Y Change
Revenue
24.3M
↑ 71.1%
Net Income
-26.5M
↑ 65.59%
Net Profit Margin
-108.74%
↑ 3.62%
FY23Y/Y Change
Revenue
37.2M
↑ 52.64%
Net Income
-28.8M
↑ 8.62%
Net Profit Margin
-77.38%
↑ 31.36%
Q4 FY22Q/Q Change
Revenue
7.6M
↑ 54.47%
Net Income
-8.5M
↑ 47.67%
Net Profit Margin
-111.22%
↑ 5.13%
Q1 FY23Q/Q Change
Revenue
9.7M
↑ 26.8%
Net Income
-9.6M
↑ 13.25%
Net Profit Margin
-99.34%
↑ 11.88%
Q2 FY23Q/Q Change
Revenue
10.0M
↑ 3.88%
Net Income
-7.6M
↓ 21.35%
Net Profit Margin
-75.21%
↑ 24.13%
Q3 FY23Q/Q Change
Revenue
8.7M
↓ 13.12%
Net Income
-7.3M
↓ 3.46%
Net Profit Margin
-83.57%
↓ 8.36%
Q4 FY23Q/Q Change
Revenue
8.7M
↓ 0.25%
Net Income
-5.0M
↓ 31.11%
Net Profit Margin
-57.72%
↑ 25.85%
Q1 FY24Q/Q Change
Revenue
7.4M
↓ 15.18%
Net Income
-4.3M
↓ 13.53%
Net Profit Margin
-58.85%
↓ 1.13%
FY19Y/Y Change
Total Assets
4.2M
-
Total Liabilities
5.1M
-
FY20Y/Y Change
Total Assets
6.5M
↑ 54.05%
Total Liabilities
10.0M
↑ 96.12%
FY21Y/Y Change
Total Assets
44.2M
↑ 576.71%
Total Liabilities
14.5M
↑ 44.52%
FY22Y/Y Change
Total Assets
50.0M
↑ 13.0%
Total Liabilities
43.8M
↑ 202.33%
FY23Y/Y Change
Total Assets
31.7M
↓ 36.58%
Total Liabilities
45.1M
↑ 2.97%
Q4 FY22Q/Q Change
Total Assets
50.0M
↑ 96.56%
Total Liabilities
43.8M
↑ 283.52%
Q1 FY23Q/Q Change
Total Assets
42.2M
↓ 15.46%
Total Liabilities
44.1M
↑ 0.73%
Q2 FY23Q/Q Change
Total Assets
43.7M
↑ 3.55%
Total Liabilities
46.4M
↑ 5.11%
Q3 FY23Q/Q Change
Total Assets
35.6M
↓ 18.56%
Total Liabilities
44.9M
↓ 3.32%
Q4 FY23Q/Q Change
Total Assets
31.7M
↓ 11.04%
Total Liabilities
45.1M
↑ 0.59%
Q1 FY24Q/Q Change
Total Assets
30.1M
↓ 5.02%
Total Liabilities
44.6M
↓ 1.18%
FY19Y/Y Change
Operating Cash Flow
-875.6K
-
Investing Cash Flow
-412.5K
-
Financing Cash Flow
1.5M
-
FY20Y/Y Change
Operating Cash Flow
-1.9M
↑ 122.61%
Investing Cash Flow
-554.1K
↑ 34.33%
Financing Cash Flow
4.1M
↑ 171.67%
FY21Y/Y Change
Operating Cash Flow
-10.8M
↑ 453.79%
Investing Cash Flow
9.6M
↓ 1840.54%
Financing Cash Flow
25.3M
↑ 520.07%
FY22Y/Y Change
Operating Cash Flow
-35.2M
↑ 226.44%
Investing Cash Flow
32.4M
↑ 236.2%
Financing Cash Flow
196.0
↓ 100.0%
Q4 FY22Q/Q Change
Operating Cash Flow
-19.9M
↑ 281.48%
Investing Cash Flow
33.3M
↓ 12906.63%
Financing Cash Flow
196.0
↑ 0.0%
Q1 FY23Q/Q Change
Operating Cash Flow
-6.5M
↓ 67.14%
Investing Cash Flow
14.7K
↓ 99.96%
Financing Cash Flow
221.0
↑ 12.76%
Q2 FY23Q/Q Change
Operating Cash Flow
-2.2M
↓ 66.37%
Investing Cash Flow
14.7K
↑ 0.0%
Financing Cash Flow
6.4M
↑ 2910152.49%

Technicals Summary

Sell

Neutral

Buy

Marpai Inc is currently in a neutral trading position according to technical analysis indicators.

More on Technical Analysis

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Marpai Inc
Marpai Inc
11.29%
-64.8%
-8.0%
-96.37%
-96.37%
The Cigna Corp
The Cigna Corp
7.74%
3.28%
24.11%
72.7%
114.25%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
5.59%
22.02%
24.51%
47.78%
156.77%
Cvs Health Corporation
Cvs Health Corporation
3.48%
-23.95%
-16.0%
-31.08%
-9.2%
Humana Inc.
Humana Inc.
2.75%
3.13%
-23.4%
-10.98%
29.26%
Elevance Health, Inc
Elevance Health, Inc
3.05%
6.93%
20.62%
51.58%
114.54%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Marpai Inc
Marpai Inc
NA
NA
NA
0.0
-13.6
-0.37
NA
-2.33
The Cigna Corp
The Cigna Corp
28.01
28.01
0.79
28.5
0.09
0.03
0.02
147.88
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
39.53
39.53
1.5
24.94
0.16
0.07
0.01
97.02
Cvs Health Corporation
Cvs Health Corporation
10.33
10.33
1.85
6.53
0.1
0.03
0.05
59.66
Humana Inc.
Humana Inc.
25.71
25.71
1.35
16.25
0.1
0.05
0.01
138.46
Elevance Health, Inc
Elevance Health, Inc
18.97
18.97
0.8
37.26
0.17
0.06
0.01
181.94
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Marpai Inc
Marpai Inc
Buy
$20.0M
-96.37%
NA
-92.77%
The Cigna Corp
The Cigna Corp
Buy
$99.3B
114.25%
28.01
1.72%
Unitedhealth Group Incorporated
Unitedhealth Group Incorporated
Buy
$551.2B
156.77%
39.53
3.66%
Cvs Health Corporation
Cvs Health Corporation
Buy
$73.1B
-9.2%
10.33
1.99%
Humana Inc.
Humana Inc.
Buy
$44.7B
29.26%
25.71
1.53%
Elevance Health, Inc
Elevance Health, Inc
Buy
$125.7B
114.54%
18.97
3.9%

Insights on Marpai Inc

  • Decreasing Revenue

    Revenue is down for the last 5 quarters, 10.04M → 7.18M (in $), with an average decrease of 7.8% per quarter

  • Decreasing Net Profit

    Netprofit is down for the last 2 quarters, -4.34M → -13.02M (in $), with an average decrease of 199.7% per quarter

  • Vs CI

    In the last 1 year, The Cigna Corp has given 25.6% return, outperforming this stock by 33.8%

Institutional Holdings

  • Vanguard Group Inc

    0.94%

  • Geode Capital Management, LLC

    0.41%

  • State Street Corporation

    0.20%

  • OMERS Administration Corp.

    0.11%

  • Tower Research Capital LLC

    0.02%

Company Information

marpai health is working at the intersection of healthcare and deep learning, the most advanced form of artificial intelligence. our mission is to predict and prevent costly events in healthcare for the benefit of patients, providers and payors.

Organization
Marpai Inc
Employees
162
CEO
Mr. Damien Francis Lamendola
Industry
Miscellaneous

Discover More

FAQs